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REPORT BY THE COMMISSION TO THE COUNCIL ON THE ADDITIONAL 
EXCISE DUTY (TAR SURCHARGE) ON CIGARETTES LEVIED BY THE UNITED KINGDOM 
I. INTRODUCTION 
1. On 19 December 1977 the Council adopted the Fifth Directive (77/805/EEC) on 
taxes other than turnover taxes, which affect the consumption of manufactured 
tobacco(!). The Directive provided for the second stage of~e harmonisation of 
these taxes which was to run from 1 July 1978 until 31 December 1980. 
2. One of the effects of Article 3 of the Directive was to amend the First 
Dir~ctive (72/464/EEC)( 2) by the insertion of a new Article lO(c). This accorded 
to the United Kingdom alone a temporary derogation permitting the charging, until 
31 December 1980, of an additional excise duty on cigarettes with a tar yield of 
20 mg or more per cigarette. 
3. On adopting the Fifth Directive, the Council invited the Commission "to report 
to it before 31 December 1980, on the implications of any levy by the United 
Kingdom of the additional excise duty allowed by Article lO(c)". 
4• In the report that follows, the additional excise duty, currently levied by 
the United Kingdom, is referred to as the "surcharge" or "tar surcharge". 
(l)OJ No. L 338, 28.12.1977, P• 22 
( 2)0J No. L 303, 31.12.1972, P• 1 
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II. BACKGROUND 
A. United Kingdom health poliqy 
5. Preoccupation with the health dangers of smoking has been a world-wide 
phenomenon for many years. A report on these dangers was published in the United 
Kingdom as long ago as 1957 and has been reinforced by the 1971 report from the 
Royal College of Physicians, linking cigarette smoki:rg and cancer, and by others. 
In its health policy, therefore, the United Kingdom government has developed a 
strategy aimed at dissuading non-smokers from beginning to smoke; at prsuading 
smokers to stop smoking or to smoke fewer cigarettes; and at mking cigarette 
smoking less dangerous for those who cannot or will not give up the habit. The 
government's long-term strategy, as stated by Sir George Young, Parliamentar,y Under-
Secretar,y of State for Health,(l) has as its objective the reduction and eventually 
the elimination~ disease caused by smoking and must use all available weapons to 
implement this strategy - health education, persuasion, control over advertising 
and, significantly, price and taxation. Ideally, there should be, he considered, 
a gradual increase in the price of tobacco in relation to prices generally. 
B. Tar and nicotine tables 
6. In particular, the United Kingdom government has accepted the results of 
research which has shwn that cigarettes with lower tar yield are relatively 
less dangerous to health. Since April 1973, therefore, the British Health 
Departments, at about 6-monthly intervals, have issued tables showing the tar 
and nicotine yields of the major cigarette brands on the United Kingdom market, i.e. 
those with annual sales of more than 10 million cigarettes. 
(l)Fourth World Conference on Tobacco and Health held at Stockholm from 18-21 
June 1979. 
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These tables are based on the regular testing of samples by the Laboratory of 
the Government Chemist. Cigarette brands on sale in the United Kingdom are 
listed in the tables in ascending order of tar yield (in mg per cigarette) and 
are divided into 5 "bands" ranging from "Low Tar" (0-10 mg) to "High Tar" (29 mg 
and over). 
c. Voluntary agreements with the tobacco industry 
7. The sampling and testing of cigarettes for these tables is carried out under 
voluntary arrangements agreed by the tobacco industry. It is a feature of the 
implementation of its health strategy that the United Kingdom government has in 
general proceeded by seeking and obtaining the co-operation of manufacturers and 
importers. 
One such agreement was finalised on 28 February 1977, some ten months before 
the adoption by the Council of Directive 77/805/EEC which accorded the derogation 
authorising the surcharge. The agreement contairedwide-ranging provisions 
including not only a code of practice on tobacco substitutes and additives and 
on cigarette packets and advertising (inclusion of a new Government health 
warning) but also the following undertakings on tar yields of cigarettes. The 
industry agreed: 
(a) to discontinue fortbath the advertsing in press, posters and cinemas 
of cigarettes yielding 29 mg or more of tar, i.e. those in the Government 
"high tar" group; 
(b) to discontinue by 31 December 1978 the advertising in press, posters and 
cine~as of cigarettes yielding 23qg to 28 mg of tar, i.e. those in the 
Government "middle to high tar" group; 
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(c) to introduce no new brand of cigarettes yielding 23 mg or more of 
tar and not intentionally to raise the tar yield of any existing 
brand to above 22 mg; 
(d) to use its best endeavours to ensure that no brands of cigarettes 
will appear in the "high tar" group of the Government tar tables 
after 31 March 1979; 
(e) to maintain its policy of devoting a disproportionate amount of 
advertising in relation to total sales to the promotion of cigarettes 
yielding less than 17 mg of tar, i.e. cigarettes in the Government's 
two lower tar groups; 
(f) to continue its long standing policy of reducing, as far as is compatible 
with consumer acceptability, the tar yield of cigarettes. 
This agreement formally expired in March 1980 but remained in force while 
discussions took place between the industry and the Health Departments on a new 
agreement. This was reached on 21 November 1980 (see paragraph 27). 
D. Trend of tar yield of cigarettes on sale in the United Kingdom during period 
of publication of the tar tables 
8. The period during which the tar tables have been published has seen a rapid 
fall in the market share taken by cigarettes yielding 20 mg or more of tar (the 
reference level for the incidence of the tar surcharge when introduced) and a 
pronounced decline in the number of brands in the Middle to High (23-28 mgfcig) 
and High Tar bands. These changes were most marked during 1973/74, i.e. during 
the opening months of the arrangements for preparation and publishing of the tar 
tables: for the year ended October 1972 the percentage of the market taken up by 
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cigarettes yielding 20 mg or more of tar was 74 %; for the year ended October 1974 
it was 21.2 %(l). By the quarter ended April 1978, the figure was 12.3,%. It is 
of note, however, that during the same period (1972-1978), although the 
proportions of the total male and female population over 16 who were smokers fell 
from 52 to 45% and from 42 to 37 % respectively, the number of cigarettes smoked 
on average per smoker per week increased from 120 to 127 for males ( + 5.~) and 
from 87 to 101 for females (+ 16.q%) (see Annex A). 
9· At the same tiDe as the fall in the market share of cigarettes yielding 20 mgf 
cigarette or more, the number of brands classified by the tar tables as being in 
the High Tar band (i.e. 29 mg or mor~) fell from 11 (out of 101) for the period 
July - December 1972 to 3 (out of 121) for the period February - July 1978. 
The number of brands in the Low Tar (undr 10 mgfcig) and Low to Middle Tar 
(11-16 mgfcig) bands together rose for the same periods from 24 to 54• 
10. It is clear from these figures that during the mid-1970s the United Kingdom's 
health policy as regards cigarettes was succeeding in two main areas; the pro-
portion of the adult popu~ion who were smokers was falling and the sale of 
cigarettes with the higher tar yields was being phased out. Furthermore, the 
sales-welPted yield of tar per cigarette had fallen from 31.4 mgfcigarette in 
1965 to 17.3 mgfcigarette in 1978( 2). In these circumstances, it can reasonably 
be asked why it was considered necessary to introduce a tar surcharge which 
would penalise higher tar cigarettes. Part of the answer lies in the changes in 
duty structure, and the consequent effect m retail prices of cigarettes, made 
necessary in the United Kingdom by the implementation of Community harmonisation 
of the tobacco excise from 1 January 1978. 
(!)Estimates by UK tobacco industry. 
( 2)Second Report of the Independent Scientific Committee on Smoking and Healtli; , 
Chairman's covering letter, 5 December 1979. 
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E. structure of excise duty on cigarettes in the United Kingdom 
11. Before 1 January 1978, the United Kingdom levied duty on cigarettes, in 
common with other tobacco products, by means of a duty on the raw tbacco leaf. 
From 1 January 1978, in accordance with the first directive harmonising tobacco 
excises(l), and on expiry of the five year derogation granted on British accession 
in 1973, the United Kingdom adopted the Community s.ystem whereby the excise is 
levied on the finished cigarette, in part as a percentage of retail price (the 
ad valorem element), in part as a fixed sum by cigarette (the specific 
element)( 2). 
12. It was recognised at the time of adoption of the first directive that the 
shift from the existing UK system to the Community system would tend to reduce 
the duty element in the price of large cigarettes relative to small, and of non-
filters to filter. On the assumption that these changes would be reflected in 
retail prices (which turned out to be the case) concern was expressed in the 
United Kingdom at the possible health implications. During discussions in the 
Council on the proposals for the second stage of harmonisation, the United Kingdom 
sought, and was accorded as part of an overall solution, a temporary derogation 
prmitting the charging of an additional excise duty on cigarettes with a tar 
yield of 20 mg or more (as referred to in paragrqh 3 above) to run for a period 
of ~years from the beginning of the second stage, i.e. from 1 July 1978 to 
31 December 1980. 
(l)OJ L 303, 31.12.1972. 
( 2)These rules apply only to the tax structure: Member States remain free to fix 
the tax rates and overall tax level; but the proportion of total tax, 
including VAT, represented by the specific element must be within a range laid 
down in the harmonisation directives. Currently, the rules require that the 
specific element should be a proportion of not less than 5% and not more than 
55 '/c of the total tax burden, including VAT. 
--------------
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III. THE UNITED KINGDOM TAR SURCHARGE 
A. Law and regulations 
13. The tar surcharge was introduced on 4 September 1978, by virtue of the 
Finance Act 1978, Section 1. Regulations made pursuant to that section(l) 
prescribed how the tar yield of cigarettes was to be determined for the purpose 
of the surcharge. Information 1o the trade was published in 
public notices Nos. 173, April 1978, and 478, August 1978. 
B. Basis of charge 
Customs and Excise 
14. The surcharge is in the form of· an addition ("supplementary duty") to the 
specific element of the basic excise duty applying to cigarettes and is levied 
on cigarettes, both imported and of United Kingdom manufacture, with a tar yield 
of not less than 20 mg per cigarette. Like the excise duties in general, the 
surcharge is administered by H.M. Customs and Excise. At the date of introduction, 
the duty increase was 25% of the existing spedfic element, i.e. the surtax was 
2q% of the total specific element of the excise duty. This met the requirements 
of Article 10 c of Council Directive 72/464/EEC, which stated that the total tax 
burden on the cigarettes to which the additional excise duty applied should not 
exceed by more than 2Q% the total tax burden which would have been imposed if 
the additional excise duty had not been levied: and that the ratio between the 
specific components of the excise duty and the total tax burden must be within the 
limits determined by the Directive. 
(l)The Tobacco Products (Higher Tar Cigarettes) Regulations 1978: Statutory 
Instrument 1978 No. 1156. 
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C. Determination of tar yield: sampling and testing procedures 
15. The tar yield is defined as the weight of the total particulate matter 
derived from the mainstream smoke of a cigarette after correction for water and 
nicotine alkaloid content. The procedure for testing for ad determining tar 
yield is lad down in the 1978 Regulations(l). The technical conditions for the 
tests are identical to the standards published by the Council of the International 
Organisation for Standards, apart from the butt lengths adopted. Rr longer 
(King-size) filter-tipped cigarettes, the United Kingdom test conditions will 
tend to give a smaller tar yield per cigarette; for all other cigarettes, they 
will tend to give a higher-tar yield per cigarette than would the I.o.s. conditions. 
16. The procedures for sampling and testing which are prescribed for the 
purposes of the surcharge are those in regular use, under the voluntar,y 
arrangements agreed with the industr,y, for production of the periodic tar and 
nicotine tables referred to in paragraph 6 above. For these tables, samples are 
invariably drawn at random, under the supervision of revenue officials at the 
point ~ manuacture or importation, and are despatched direct to the Laboratory 
of the Government Chemist for testing. The normal sample consists of 5 packets 
of 20 cigarettes of each brand, from~ch of which 5 cigarettes are tested. The 
sampling is done in each of 6 consecutive months. It is followed, on completion 
of the testing programme, by calculation of mean values and consultation with the 
traders concerned, many of whom will have carried out parallel tests on duplicate 
samples. There is an understanding that the results of the tests should remain 
confidential until any disagreement has been resolved and the tables published, 
a position only reached some months after the end of the 6-month sampling cycle. 
(l)The Tobacco Products (Higher Tar Cigarettes) Regulations 1978: Statutory 
Instrument 1978 No. 1156. 
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17. For surcharge purposes, the manufacturer or importer has to declare whether 
or not the cigarettes he has made or imported have a tar yield of below 20 mg. 
The basic objective of the sampling and testing procedures is to check periodically 
the accuracy of these declarations. If the trader declares the tar yield to be 
20 mg or more or where his declaration that the tar yield is below this level is 
supported by adequate evidence, no sampling for surcharge purposes may be necessary. 
Additional sampling is therefore very largely confined to minor brands of which 
production or importation may be irregular or to occasions when there is reason 
to believe that a critical change in tar yield has occured or is about to occur. 
If test checks, in whatever circumstances, reveal a tar yield which is inconsistent 
with the declaration, further tests m~ be required. The existing declaration may, 
however, continue to be accepted, provided that the Customs and Excise are 
satisfied that any unexpectedly high tar yield is not deliberately pnduced and 
that any action necessary to restore it to the normal level is taken by the trader 
without delay. The basic criterion for determining the tar yield remains the 
6-month rolling average determined by the Government Chemist for the purposes of 
tar and nicotine tables. In practice, the surcharge is not levied if there is 
reasonable doubt that the cigarettes in question have a tar yield of 20 mg or more. 
18. Traders who wish to market in the United Kingdom brands which have not been 
previously tested, or have been subject to a specification change which could 
affect duty liability and who do not have access to suitable testing facilities, 
may request to have the tar yield determined by official testing. Where a need 
for this facility is shown, Customs and Excise then arrange for brands to be 
tested by the Government Chemist, free of charge to the trader. 
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19. Once a brand has been tested and its tar yield established, occasional 
sampling and testing will follow, the quantity and frequency depending on the 
timing and size of production runs or importations and the proximity of the 
established yield to the 20 mg threshold. 
IV. :EFFECTS OF THE TAR SURCHARGE 
A. Objectives 
20. Historically, taxes on cigarettes have had the ohiefaim of raising revenue. 
By contrast, the tar surcharge has as objective the reduction and even elimination 
of sales of the particular type of cigarette to which it applies, with the 
consequence that its success is in inverse proportion to its revenue yield. 
B. Revenue yield 
21. As indicated in the previous paragraph, the surcharge is not a revenue-
raising measure. During the first 7 months of operation, the estimated revenue 
from the surcharge averaged £337,000 per month. In April 1979, however, the 
biggest brand which had been hitherto subject to the surcharge became no longer 
so and, since then, the average monthly yield from the surcharge has been less than 
£57,000. The total surcharge collected in the 21 months for which figures are 
available (September 1978 to ~ 1980) was about £3.15 million. By 
comparison, the total excise duty collected on cigarettes averages about £7 million 
a dey. 
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C. Fall in market share of higher tar cigarettes 
22. Price competition on the British market in recent years has been fierce, 
with switches in brand loyalties being sought via price differences of as little 
as 1 p or 2 p per packet. (If fully passed on to the consumer, the surcharge 
raises the price by up to 7 p a packet of 20). Consequently, the effects of the 
typical price of higher tar cigarettes moving overnight from, for example, 70 p 
to 77 p were immediate and dramatic. Prior to the introduction of the surcharge 
(see paragraph 8 above), the proportion of cigarettes yielding 20 mg of tar or 
more represented 12.3 ~ of total cigarette sales. During the first 4 months 
of the operation of the surcharge (September-December 1978) this proportion fell 
to 1*%. By April 1979, the share had fallen to about 0.25 ~(l) and it has 
remained at about this level up to ~ 1980, the latest month for which figures 
are available. 
23. Furthermore, in November 1979, the United Kingdom Department of Health 
announced that the number of cigarette brands in the "Middle-to-High" (23-28 mg) 
and "High Tar" (29 mg and over) categories had fallen to 13 out of 129 brands 
on the market (10.1 ~), whereas, before the introduction of the surcharge in 
September 1978, 33 brands out of 127 (26.0 ~) were in the higher tar categories. 
The average tar yield of all brands was said to be more than 4 ~ less than the 
previously tested sample (16.6 1J8 against 15.9 ug)( 2). The tar table published in 
~ 1980, relating to the period April to September 1979, showed, for the first 
time, no brands in the High Tar category: the sales weighted tar yield averaged 
16.6 mgfcigarette. 
(l)H.M. Customs and Excise 
( 2)ASH Information Bulletin No. 41, 13.12.79 and UK Department of Health. The 
tar yield average figures of 16.6 and 15.9 are not sales weighted. 
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24. The fall in consumption of these higher tar cigarettes was not mere~ the 
result of declining consumption of the brands affected but rather of action 
taken by manufacturers ad importers to alter brand specifications or to 
introduce new, lower tar, brands. For example, during 1978, tests confirmed 
32 significant composition changes, of which 22 had the effect of reducing 
the tar yield of the brand in question to a level below the surcharge 
threshold. The great majority of these changes took place in the months 
immediate~ preceding the introduction of the surcharge, continuing the 
downwards trend in tax yield that had been taking place for some years (see 
paragraph 10 above). Moreover, it has tQ be remembered that reductions in tar 
content in accordance with the 1977 agreement were going ahead concurrent~. 
Nevertheless, it seems reasonable to conclude that a large proportion of the 
specification changes resulted from the surcharge or were carried out in 
anticipation of its introduction. 
25. Now that the market share held by cigarettes attracting the surcharge is 
so small a base from which to calculae, it will be difficult to ascribe any 
further downward movement either to the long term trend or to the effect of the 
surcharge. What can be said with certainty, however, is that the objective 
of eliminating higher tar qgarettes from the market has been virtually achieved. 
D. Effects on the weighted average of tar yield of all brands 
26. Between 1965 and 1978 (that is, prior to the introduction of the surcharge 
see paragraph 10 above) the sales-weighted tar yield per cigarette fell from 
31.4 to 17.3 mgfcigarette(l). For the period April to September .1979 
(l)Second Report of the Independent Scientific Committee on Smoking and Health; 
Chairman's covering letter, 5 December 1979. 
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the figure had further fallen to 16.6 mgfcigarette. Moreover, it should be 
remembered that, by· its nature, the surcharge has a once-for-all effect. The 
overall impact of the surcharge on average tar yield can therefore be broadly 
gauged by comparing the average tar level actually reached by September 1979 
(16.6 mg) with a projection of the trend already observed between 1965 and 1978. 
According to the 1979 report cited above, the average sales-weighted tar yield 
was falling between 1973 and 1977 at a rate of 0.3 mg per year. Projecting this 
rate forward (and taking no account of any acceleration in the rate of fall 
which might be expected from the 1977 voluntary agreement referred to in 
paragraph 7) the swe figure of 16.6 mg is obtained by the end 
of 1979. Even allowing for the possibility that, despite the voluntar.y 
agreement, the rate of fall would gradually slow down, the trend_ suggests that 
an average tar yield of 16.6 mg/cigarette would have been reached by the end of 
1980 at the latest. 
27. Bearing in mind the once-fir-all effect, the conclusion to be drawn is that 
the surcharge m~, at most, have advanced by perhaps 18 months, the 
date on which the level of 16.6 mg/cigarette was reached. Since that time, the 
surcharge has had no significant effect on the long-term trend and has served 
merely as a safeguard against the re-introduction of higher-tar brands. These 
effects are closely akin to those of a prohibition. However, given the established 
trend aw~from high-tar cigarettes, the commercial attraction to manufacturers 
in seeking to launch new high-tar brands is remote. Consequently, once the 
initial objective of the surcharge had been achieved, its value as a safeguard 
against the possibility of new high-tar brands became doubtful, to s~ the least. 
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Indeed, a new agreement was reached on 21 November 1980 between the British 
government and the two trade associations representing United Kingdom manufacturers 
and importers which includesthe following:-
a) There will be no media advertising of cigarettes with a tar yield of 
20 mg or more. 
b) No new brand will be introduced giving a tar yield exceeding the reducing 
sales-weighted average of brands in the middle tar band. (Currently, that 
average is 18.3 mg; it is to be reduced, under this agreement, to "about 
15 mg" by 31 December 1983). 
c) The tar yield of any brand will not be intentionally increased from less 
than 20 mg to 20 mg or more. 
Furthermore, individual manufacturers had, in September 1980, given undertakings 
to the British government to maintain unchanged relative to the prices of other 
cigarettes the prices of cigarettes subject to the surcharge on its abolition. 
V. TRENDS OVER COMPARABLE PERIODS OF AVERAGE TAR YIELD ON THE OTHER EEC MARKETS 
28. During the last 25 years, the health hazards associated with tobacco smoking 
have been increasingly recognised throughout the world and ma~ governments have, 
by legislation or other means, introduced a variety of measures, including 
restrictions on the tobacco industr,y, with a view to reducing the health dangers. 
29. In their own w~s and to different degrees the Member States of the Communi· 
have each followed that path. The United Kingdom is, however, the only Member 
State to publish regular official tables of tar (and nicotine) yields of 
individual brands (see paragraph 6). No comparison between the Member States 
of tar yields based on official data is therefore possible. Even if such 
statistics existed, no strict comparison of absolute tar levels, as distinct 
from trends, could be made, as the mahods of measurement of the substances 
yielded by tobacco smoke have not been standardised throughout the Community. 
In a~ case, as the results of the intercomparability study referred to in 
paragraph 34 indicate, measurement of tobacco smoke condensate can var,y 
significantly. 
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30. Nevertheless, the Commission has assembled such data as are available from 
unofficial sources (see Annex B) and these support the conclusion that in all 
Member States, the profile of cigarettes smoked tod~ is very different from those 
smoked even 15 years ago. As in most other industrialised states, the 
consumption of filter-tipped cigarettes has increased (in the Community, from 
51% to 8C1/o of total consumption), the share of markets occupied by "higher tar" 
cigarettes has dropped dramatically and the average tar yield of cigarettes has 
fallen steadi~ and continues to fall. 
31. It is worthy of note that, by the time the United Kingdom introduced the 
health surcharge in 1978, it was alrea~ the Member State with the highest 
proportion of sales of filter cigarettes. Data on the trend in the fall of tar 
yields in other Member States are incomplete. Nevertheless, by comparison with 
the trends in France and Germany for which some reliable data are available, 
the rate of fall of tar yield (measured in mg per year) in the United Kingdom 
was considerably greater. It is probably true to say that, prior to the 
introduction of the surcharge in September 1978, the average tar content of 
cigarettes on the United Kingdom market was, as it is now, among the lowest in the 
Community. 
VI. EVALUATION OF THE EF'FECTS ON HEALTH OF SMOKING TOBACCO 
32. World-wide research, both clinical and epidemiological, into the effects of 
smoking on health has been conducted for many years. For this report, the 
Commission has not attempted to duplicate that research but, early in 1978, put 
in hand work on two topics which appeared to be of particular relevance. 
For each topic, two independent studies were commissioned, four independent 
studies in all. 
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33. The first two studies, carried out by the Centraal Instituut voor 
Voedingsonderzoek, Zeist and the Ecole de Sant6 Publique de l'Universit6 
Libre de Bruxelles, were to evaluate, on the basis of the literature, the 
effect on health of tar, nicotine and other harmful substances resulting from 
the consumption of tobacco. 
34. The other two studies1 into methods of measuring the proportion of noxious 
products found in the smoke of cigarettes, were carried out by the Fresenius 
Institut, Wiesbaden and the Laborator.y of the Government Chemist, London. 
These studies were accompanied b,y an intercomparison programme performed by 
the above two institutes in conjunction with two others: the 
Bunde~esundheitsamt, Berlin, and the Nederlandse Organisatie voor Toegepast 
Natuurwetenschappelijk Onderzoek, Apeldoorn. The programme showed that differences 
of up to 30% in the particulate and nicotine yields could be Qbserved, but that 
these differences were not systematic: they occurred when either the same or 
different sampling techniques -were used. 
35. It is difficult to avoid the conclusion that the tar deliver,y of cigarette 
smoke cannot as yet be controlled - or indeed measured - consistently. Indirect 
confirmation of this view can be found in the testing procedures (see paragraphs 
16 and 17 above) used by the British authorities in applying the surcharge and, 
in particular, in their reliance on a six-months rolling average as the basic 
criterion for determining the tar yield and therefore the liability to the 
surcharge. 
36. The services of the Commission have prepared a s.ynthesis of the evidence 
contained in the above studies. This is set out in Annex c. 
37. In the light of this evidence, the following conclusions m~ be drawn:-
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Cigarette smoking has been demonstrated to be causally related to or 
significantly associated with several diseases. These include cardio-
vascular disease, cancer (in particular of the lung), chronic bronchitis 
and emphysema, and peptic ulcer. Of these, cardiovascular disease is the 
most significant cause of mortality in the Member States. 
- Nicotine and carbon monoxide contained in tobacco smoke are of particular 
importance in view of their known adverso effects in cases of cardio-
vascular disease. 
Cancer is also an important cause of mortality, and both fresh tobacco 
smoke and tobacco smoke condensate have been shown to exhibit carcenogenic 
activity in animal studies. 
Intercomparability studies have shown that the results of measuring 
tobacco smoke condensate and nicotine in tobacco smoke var,y considerably. 
These results lead to the conclusion that it is not at present possible 
to establish meaningful limits for these two components of tobacco smoke 
which could be uniformly applied throughout the Member States. 
- From the viewpoint of public health, any approach to reduce mortality 
associated with cigarette smoking is to be welcomed. However, the main 
aim should be to reduce overall morlality by reducing cigarette smoking 
to a minimum. The evidence available is therefore adequate to justify 
a reduction in overall cigarette smoking, but is inadequate to justify 
the proposition that a reduction in a component of tobacco smoke, such 
as tobacco smoke condensate, is preferable as. a public health policy 
throughout the Member States. 
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VII. IMPLICATIONS OF THE UNITED KINGDOM TAR SURCHARGE FOR THE COMMUNITY 
A. The tar surcharge as model for the Community 
38. In accordance with Article lO(c) of Council Directive 72/464/EEC, the 
United Kingdom derogation to apPlf the surcharge will come to an end on 31 
December 1980. Leaving to one side the question of whether or not much the same 
result would have been obtained over a comparable time-scale via the system of 
voluntar,y agreement in application since 1977 between the Government and the 
British tobacco industr,y, the surcharge can be said to have fulfilled the 
objective (see paragraph 20 above) of effectively eliminating from the market 
cigarettes with a tar yield of 20 mg or more. In the Commission's view, the 
surcharge should be seen as part of the process of adaptation by the United Kingdom 
from a system of taxing tobacco by reference to the weight of the raw leaf to 
the Community system of taxing cigarettes in part by a specific amount and in 
part by reference to the retail price. Now that the first two stages of the 
harmonised system (and in particular the first, which required considerable 
adaptation) have be~applied by the United Kingdom, the surcharge can be seen 
to have fulfilled its role. Indeed, as pointed out in paragraph 27 above, the 
virtual disappearance of higher tar cigarettes from the British market, the under-
takings of manufacturers and the new voluntary agreement reached in November of this 
year mean that the surcharge no longer serves ~ useful function. 
39. Nevertheless, the tar surcharge represents an experiment in seeking to 
influence consumers towards lower-tar cigarettes via the price mechanism and 
the question to be considered is whether this experiment offers a model which 
the Community as a whole should seek to follow. 
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40. It can of course be argued that the surcharge in fact operated as a 
prohibition, rather t~an a true tax, in that the rate of the surcharge was 
such that consumers and manufacturers simply abandoned cigarettes to which 
it applied. Indeed, such a conclusion has alreaQy been drawn earlier in this 
report. In that event, it mey reasonably be asked whether a tax instrument in 
fact enjoys any significant advantage over a simple prohibition. It has of course 
been argued that a tax is a less repressive measure than a prohibition, but this 
argument cannot it seems be valid when, as in this case, iB tax has effects 
closely comparable to those of a prohibition. Moreover, a tax introduces its 
own inequities, in that the freedom of choice implied by use of the price 
mecha.niBll :i3 more readily available to the better-off than to the poor. Finally, 
it is somewhat pradoxical that, in order to deal with a risk identified as of 
sufficient gravity to make legislation imperative, the legislation itself Shotitl 
be limited to influencing the individual's choice as to whether or not to incur 
the danger in question. 
41. It should be noted that Article 36 of the Rome Treaty accords Member States 
considerable latitude in dealing with dangers to public health. The agreement 
between the British Government and the national industr,y, whereby manufacturers 
voluntarily reduce the tar yield of cigarettes, is an example of a measure aimed 
at protecting an· interest referred to in Article 36(l). Such measures have a 
further- and not inconsiderable --advantage of dispensing with many of the 
procedures and formalities_which are inevitably linked to a tax, even when the 
tax is only rarely collected. 
(l)Though Article 36 cannot, of course, be used to justify a measure 
whose scope is wider than is necessary to protect such an interest. 
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B. Constraints on trade 
42. But to conclude that a prohibition or some form of agreement between 
government and manufacturers is a more logical ad administratively less complex 
mechanism than a tax does not wholly resolve the issue of whether or not the 
tar surcharge should serve as a model for future Community action in the field 
of smoking and health. After all, whether a given measure is a tax, a 
prohibition or some informal agreement between government and industr,r, the 
effect remains one of a constraint on free trade. It is in principle undesirable 
that the Member States should individually apply a variety of different constraints 
to trade in tobacco products, or that some Member States should impose constraints 
whilst others do not. 
43. Nevertheless, the fundamental question to be posed is whether the risk of 
trade constraints or distortions, arising from differing policies on smoking and 
health in the Member States, is sufficient in itself and in the absence of 
Community health objectives, to require Community action to harmonise those 
policies. This question has been posed in other sectors - for example, in 
relation to the regulations governing the construction of passenger vehicles, 
where the risks to trade were manifestly of sufficient scope and importance to 
warrant the proposal and adoption of Community directives. 
44• In the tobacco sector, however, it should first be noted that the 
Commission has received no representations whatsoever from cigarette producers, 
requesting Community legislation in the field of smoking and health. Trade 
considerations cannot therefore be regarded as of sufficient importance to 
require Community intervention. 
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c. Health considerations 
45. Turning to health considerations, Section V shows that a generalised 
trend towards cigarettes with a lower tar yield is alread;y well established 
in the Member States, and seems likely to continue independently of arr;y 
Community initiatives. So far as smoking is concerned, the Council has so 
far limited its activities to exchanges of information about national health 
education campaigns and the Commission has made clear in recent Parliamentary 
replies (Written Questions Nos. 103/79(l), 645/79( 2), 1426/79( 3) and 
331/80(4 )) that it does not itself regard this area as ripe for Community 
action without further studies, for example, on w~ people smoke. In arr;y 
case, a reduction in the tar yield of cigarettes is not necessarily s.ynonymous 
with an improvement in the health of smokers who mq, when switching to 
lower tar cigarettes, compensate by smoking more cigarettes, by inhaling 
more deeply or by smoking them further to the end. It is difficult to see 
how aqy polic,y instrument, national or Community, could control this aspect 
of consumption. 
D. Practical difficulties of Community application 
46. Finally, leaving to one side the question of whether or not, and whether 
(l)o.J. c 185, 23·7· 79 
(2)o.J. c 316, 17.12.79 
(3)o.J. c 126, 27.5.80 
(4)o.J. c 217' 25.8.80. 
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on trade or health policy grounds, detailed Community provisions in the field 
of smoking ad health are desirable, it cannot be denied that the formulation of 
such provisions would face formidable obstacles in practice. There is as yet 
no general agreement {see Section VI) on what elements in tobacco smoke constitute 
the most serious health hazards: nicotine and carbon monoxide are widely regarded 
as presenting health hazards as great, if not greater than, those presented by 
tar. Even if agreement could be reached on the hazards to be countered, smoking 
habits in the Member States differ considerably. (Note for example the differing 
proportions of filter cigarettes on the nine markets and the different levels 
of average tar yields •) It would therefore be difficult, if not impossible, 
to reach agreement on what constituted acceptable levels for each hazard. Lastly, 
the results of measuring tobacco smoke condensate and nicotine can var,y so 
considerably (see Section VI) that, even assuming limits could be agreed for these 
components, it would be~tremely difficult in practice to apply them in uniform 
fashion. 
47. For these reasons, the Commission considers that Community initiatives 
similar in scope or form to the United Kingdom surcharge are neither necessary 
nor desirable at the present time. 
E. Possible measures by the Community 
48. As a possible alternative, the Commission has also considered whether more 
general poliqy guidelines should be proposed in relation to smoking and health; 
in particular, in view of the fact that the medical evidence clearly supports a 
policy in which the reduction of cigarette smoking overall is given priority over 
a reduction in the smoking of certain cigarettes, or in certain components in 
tobacco smoke. 
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49. One possibility would be for the Community to agree certain guidelines for 
the tax levels to apply to tobacco, or at least for the wey in which tax rates 
should evolve relative to prices. But it should be stressed that there are no 
trade ~ fiscal consideratbns which would require partial or total harmonisation 
of tobacco taxes in advance of the harmonisation of other indirect tax rates, and 
the justification for such guidelines would therefore rest wholly on health 
cons ide rat ions. 
50. Agreement on such guidelines would have major budgetary and political 
implications for the Member States. Excises on manufactured tobacco, expressed 
~a percentage of total tax receipts,· including social security contributions, 
var,y between 0.71% in France (1978) and 4.79 in Ireland (1977) , whilst 
tax incidence on cigarettes, expressed as a percentage~ retail price, also 
varies considerably, between nearly 62% in Luxembourg and over 88 tfo in Denmark. 
Examination of the evolution of cigarette taxes in the Member States in recent 
years gives some indications~ the difficulties likely to be encountered. The 
tables at Annex D show the evolution of the tax rates and of the consumer price 
index in the Member States since 1973. In 4 Member States tax rates have 
increased since 1973 by more than the consumer price index. In the other 
Member States, tax increases have fallen behind to such an extent that further 
increases of up to 59% would be required to restore the 1973 tax incidence. (It is 
particularly striking that, notwithstanding the British Government's concern over 
smoking and health, the shortfall between the increase in cigarette taxation 
relative to the increase in prices overall in the United Kingdom is amongst the 
largest in the Community). These factors suggest that the possibilities of the Member 
States adopting a common policy as regards either the absolute level or the evolution 
of cigarette taxes are slim. The Commission is, however, prepared to explore these 
possibilit:Bs h the light of future discussions on a Community health policy. 
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VIII. UNITED KINGDOM REQUEST FOR EXTENSION OF THE DEROGATION 
51. During the final stages of preparation of this report, the United 
Kingdom requested the extension to all Member States, on a permanent basis, 
of the existing derogation due to expire on 31 December 1980. Before any 
decision is taken on the United Kingdom request, it is desirable that adequate 
time be given for stuqy of this report. For this purpose, the Commission 
accepts a limited prolongation of the existing derogation in favour of the 
United Kingdom, for 6 months only. 
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IX. CONCLUSIONS 
1. 
2. 
During the mid-1970s and before the introduction of 
the tar surcharge in September 1978, the United 
Kingdom's health poliqy was succeeding in reducing the 
proportion of adults who were smokers, the proportion of 
cigarettes with higher tar yields, and the average tar 
yield of cigarettes as a whole. 
The effect of the impending or actual surcharge on the 
market was dramatic: higher t~r cigarettes (yielding 
20 mg or over of tar per cigarette) have been virtually 
eliminated from the United Kingdom market. 
The surcharge has had little or no effect on the sales-
weighted average tar yield of cigarettes. 
The surcharge no longer serves any useful purpose as 
a safeguard against the resurgence of the "higher tar" 
sector of the market: indeed United Kingdom cigarette 
manuacturers a.nd importers have Biven assurances to the 
British government which would provide just such a 
safeguard. 
In the 8 ether Member Staas, where no tar surcharge has 
been introduced, the increasing consumption of filter 
cigarettes, the decreasing consumption of higher tar 
cigarettes and the steady fall in the average tar yield of 
cigarettes, indicate trends similar to those in the United 
Kingdom. 
Report Paragraph 
10 
24-25 
26-27 
27 
30 
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Report paragraph 
Cigarette smoking has been demonstrated to be causal~ 
related to, or significantly associated with, several 
diseases; smoke condensate (tar), nicotine and carbon 
monoxide are all important noxious agents. 
Intercomparability studies have shown that the results of 
measuring tobacco smoke condensate and nicotine in tobacco 
smoke var,y considerably. 
37 
37 
It is not at present possible to establish meaningful limits 37 
for the "tar" and nicotine components of tobacco smoke which 
could be uniform~ applied throughout the Community. 
The evidence available on the links between smoking and ill 
health is adequate to justify a reduction in overall cigarette 
smoking but is inadequate to justif,y the proposition that a 
reduction in a component of tobacco smoke, such as tobacco smoke 
condensate, is preferable as a public health policy throughout the 
Member States. 
37 
Conceived in the context of the United Kingdom's adaptation 38 
of its system of tobacco taxation to that of the Community, the 
surcharge has fulfilled its role. 
11. 
12. 
13. 
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Report paragraph 
A general trend towards cigarettes with lower tar 
yields is alrea~ well established in the Member 
States and seems likely to continue independently 
of any Community initiatives. 
Community initiatives similar in scope or form to the 
United Kingdom surcharge are neither necessar,y nor 
desirable at the present time. 
The Commission is prepared to explore the possibility 
of framing proposals providing for the convergence or 
the indexation of tobacco excise rates in the Member 
States. Obtaining Community agreement to such 
proposals is, however, likely to be extremely difficult. 
In order to provide sufficient time for the study of 
this report, the Commission accepts a limited 
prolongation of the existing derogation in favour of 
the United Kingdom, for 6 months only. 
45 
47 
50 
51 
SMOKING IN THE UNITED KING:OOM 
Table 1 
Prevalence 
Annex A 
(referred to in paragraph i 
Percentage of population aged 16 and over who are current cigarette smokers 
1972 1974 1976 1978 
Males 52 51 46 45 
Females 41 41 38 37 
Table 2 
Consumption of cigarettes 
Average number of cigarettes smoked per smoker (aged 16 or over) per week 
1972 1974 1976 1978 
Males 120 125 129 127 
Females 87 94 101 101 
Source (Tables 1 and 2) : United Kingdom Office of Population Censuses and 
Surveys Monitor GHS 79/1. (cited in ASH Information 
Bulletin 30, 21.6.1979). 
Annex B 
(referred to in paragraph 30) 
TRENDS IN CONSUMPTION OF FILTER AND HIGHER-TAR CIGARETTES AND IN AVERAGE TAR 
YIELDS IN THE MEMBER STATES 
Table 3 
Proportion of filter cigarettes in total sales of cigarettes 
Year B DK D F IRL IT NL 
1965 50.0 39.1 81.6 24.0 35.0 39.6 19.5 
1970 61.8 47.8 84.2 38.3 66.7 6o.o 37 .o 
1971 64.0 48.3 84.8 42.4 71.0 66.8 40.3 
1972 66.9 49.5 85.1 46.6 74.2 71.8 43-7 
1973 68.0 51.9 85.2 50.9 78.0 80.1 46.8 
1974 72.2 52.6 84.8 53.8 80.1 87 ·5 49.0 
1975 75.1 53·5 86.0 56.7 81.0 84.3 50.9 
1976 77.2 56.6 86.4 59·9· 81.3 85.0 54.0 
1977 78.9 59·7 86.9 58.4 - 86.6 55·7 
1978 79.1 60.6 87.2 58.3 85.0 86.7 57·9 
Source - Bron "Maxwell International Estimates" 
Table 4 
Proportion of "higher tar"(l) cigarettes in total sales of cigarettes 
Tar yield in mgfcigarette(l) 
Year 20 or more 15 or more 
B D NL UK D 
1972 14 74 63 
1973 58 95 49 
1977 11 13 ) 12 fl2~2 
1978 13 10 2 3) 
1980 < 1 
( %) 
UK 
53.0 
78.3 
79.8 
81.7 
83.0 
84.5 
86.6 
88.1 
89.5 
90.5 
(l)The term "higher tar" has no precise meaning in this context and is used merely for 
convenience. It is emphasised that the values shown in the table m~ not be strictly 
comparable because methods of measurement of tar yield have not been standardised 
(
2
)throughout the Community 
Pre 4.9.78 
(3)Post 4.9. 78 
Source: UK industry estimates. 
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Table 5 
Average tar yield(l) of cigarettes 
Year 
1961 
1965 
1966 
1970 
1973 
1975 
1976 
1978 
1979 
1980 
Sources: 
(mg/cigarette) 
DK D F UK 
e. 28.3 
a. 30.5 b. 31.4 
e. 22.7 
•• 18.2 
b. 18.7 
e. 15.2 
a. 18.6 
a. 20.0 b. 17.3 
d. 16.6 
c. 25.3 
a. Tobacco-Health Working Group of the EEC 
Consultative Committee on raw tobacco: report 
of meeting on 21 November 1979. 
b. Independent Scientific Committee on Smoking and 
Health: Second Report, 1979; and Chairman's 
covering letter. 
c. Danish Ministr,y of Fiscal Affairs. (Figure based on 
88% of the market) 
d. UK Department of Health and Social Security. 
e. Federation Belgo-Lu:x:embourgeoise des Industries du 
Tabac: Revue, September 1979. 
(l)See footnote(l) to Table 4• 
Paragraph 
1. 
2. 
6. 
Annex C 
(referred to in paragraph 36) 
EVALUATION OF THE EFFECTS ON HEALTH 
OF SMOKING TOBACCO 
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1. INTRODUCTION 
This annex summarises the effects on health from smoking tobacco. It makes 
particular reference to cigarette smoking and the effects on human health of 
tar and other constituents of cigarette smoke. 
2. THE: CONSTITUENTS OF TOBACCO SMOKE AND THEIR ANALYSIS 
2.1 Constituents 
The term "tobacco smoke" includes both a gaseous and a particulate phase. 
The main constituents of the gaseous phase include carbon monoxide, oxides of 
nitrogen, acetaldehyde and acrolein. 
In quantitative terms the main constituents of the particulate phase are water 
and nicotine. 
A recent compilation of the many compounds, reported as being present in tobacco 
smoke lists more than 2300 compounds most of which reside in the particulate 
(tar or condensate) fraction. 
2.2 Analysis 
As it is not practical to measure all these compounds routinely, three parameters 
(tar, nicotine and carbon monoxide) are generally used to characterise smoke 
yields of cigarettes. For analytical purposes smoking machines of var,ying 
designs have been developed to imitate the principles of human smoking in a 
reproducible w~. Some countries have national standards for smoking, smoke 
collection and analysis, but ISO has, as yet, only standardized the principles 
of the smoking machine operation. Different methods m~ produce different 
results and the main factors affecting such differences are likely to be: 
a. preconditioning of cigarettes 
b. smoking room environment 
c. smoking machine design and operation 
d. smoke collecting or trapping s,ystems 
e. butt length 
f. methods of analysis for water, nicotine and CO 
g. d~-to-d~ variation in performance ofa, b, c, d and f. 
2.3 Conclusions from interlaborato;y trials 
A Working Group which included representatives from four independent laboratories 
within the Community was set up by the Commission services. This Working Group 
was charged with the organization and performance of interlaboratory 
collaborative trials and selecting the factors requiring evaluation in assessing 
the toxicity of tobacco smoke. It was decided to give particular attention to the 
yields of tar, nicotine and carbon monoxide (CO). Two collaborative trials were 
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undertaken and differences in the results obtained from different combinations 
of smoking machines, trapping systems and analytical methods were reviewed. 
The findings relate to two trials using five brands of filter cigarettes in, 
respectively, three and four laboratories with three smoking machines and three 
types of trapping systems. 6000 cigarettes were examined over a period of 
several months. For carbon monoxide, the results were reasonably consistent 
across all laboratories. 
For nicotine, laboratories using different machines and methods found differences 
of about 0.3 mg at the 1.5 mg level. 
When using the same trapping system there were differences in tar yield of up 
to 15 ~between laboratories using different machines. Within two laboratories 
there were differences of up toil5 ~ according to whether filters or electro-
static traps were used. Using different machines and traps, mean values between 
14 and 19 mg tar per cigarette have been found for two individual brands. 
Within laboratories using one type of machine and trap and their own analytical 
methods the range of results for these analytes is ver.y much smaller. 
Although the Working Group has assessed the influence of the most relevant 
factors, the trials were of a limited nature and the explanations of the 
differences in analytical results reported by the various laboratories are 
far from complete. There are at present insufficient data to derive accurate 
correlation factors for each analyte. These analytical differences are not 
expected to affect national ranking between brands but do not permit pooling 
national data to set up a Community ranking system. For the latter purpose, 
in the absence at this time of agreed international procedures, correlation 
factors between different national methods will have to be developed. 
3. THE CONSTITUENTS OF TOBACCO SMOKE AND THEIR EFFECTS 
Tobacco smoke has been shown to contain enzyme inducers, to be carcinogenic and 
to possess irritant properties. The enzyme inducers include polynuclear 
aromatic hydrocarbons, nicotine, cadmium, some pesticides and acrolein of 
which the most potent inducers are probably aromatic hydrocarbons which are 
ver.y persistent in tissues. 
Tobacco smoke condensate was found to have strong mutagenic activity, which 
could not be explained Qy its benzo(a) pyrene or nitrosamine content; 
nitrogen-containing compounds are thought to be responsible for this mutagenic 
activity; some other p,yrolysis products of amino acids are regarded as possible 
comutagens. 
Tobacco smoke condensate has shown al~lating potential. Methyl chloride, one of 
the major components of smoke, is a known al~lating compound and a mutagen. 
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The carcinogenic activity of fresh tobacco smoke as such has been unequivocal~ 
demonstrated in inhalation studies with Syrian golden hamsters, in which early 
invasive cancer of the lar,ynx was found following repeated exposure to cigarette 
S!DOke. 
The carcinogerib properties of tobacco smoke condensate (TSC) have been 
de •onstrated in several animal species by skin painting, subcutaneous injection, 
application on the mucosa of the oral cavity, trachea or cervix and intratracheal 
instillation. 
Tobacco smoke condensate has been found to contain strongmmour-enhancing activity, 
established promoters, co-carcinogens and initiators of tumours. 
Tobacco smoke has a ciliostatic, cytotoxic and mucous-producing activity due to 
the presence of irritant substances such as acrolein, acetaldehyde, phenols, 
hydrogen cyanide, ammonia, acids and nitrogen and sulphur oxides. These irritants 
in tobacco smoke m~ encourage infection and m~ be responsible for a prolonged 
contact of the respiratory epithelium with carcinogens. They induce immediate 
coughing during or after inhalation of tobacco smoke and m~ be responsible for 
chronic bronchitis and emphysema in ~mokers. 
Nicotine is a pharmacologically active alkaloid, which actsm the central and 
the automatic nervous ~stem, and which enhances the production of adrenaline. 
Because of this adrenaline release, nicotine indirectly influences the heart, 
the peripheral blood vessels, the thrombocytes, the clotting of the blood and 
also the metabolism of carbohydrates and fats, but it is not possible to ascribe 
to nicotine - in the amounts present in smoke - chronic effects on the development 
of arteriosclerosis. Although nicotine in smoke has no adverse effect on a 
healthy heart, its absorption by someone suffering from coronar,y sclerosis can 
result in an acute attack of angina pectoris as a consequence of lack of oxygen. 
Nicotine has been shown to be the compound in tobacco smoke that is most likely 
responsible for the reinforcing properties of tobacco. It has been demonstrated 
that nicotine readily crosses the blood-brain barrier. Tobacco smoking has been 
found to prevent deterioration of reaction time, and improves learning and 
efficiency. These effects m~ be of benefit to smokers and m~ reinforce 
maintenance of the smoking habit. There is some evidence that the withdrawal 
~ndrome is more severe in women than in men. This m~ at least partly be 
responsible for less successful cessation of smoking among women. 
Carbon monoxide (co) is main~ formed as a result of incomplete combustion of 
tobacco. Its affinity for haemoglobin (= the oxygen-carr,ying red pigment of the 
blood) is 200 times higher than that of oxygen itself. Heavy smokers often have 
as much as 15% carboxyhaemoglobin (COHb) in their blood, which means a reduced 
capacity for transport of oxygen and for the liberation of oxygen from 
oxyhaemoglobin. This disturbance of both the transport and utilization of 
oxygen m~ lead to hypoxia, which particularly m~ affect organ ~stems with a 
relatively great need of oxygen such as the heart and the central nervous system, 
and also the foetus. 
Whether exposure of humans to CO as such m~ lead to atheros•::lerosis is still 
doubtful. However, CO most likely is a factor which together with high fat diet, 
stress, hereditar,y disposition and tobacco smoke compounds other than CO, is 
responsible for the high incidence of cardiovascular disease in the modern Western 
society. 
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4• PASSIVE SMOKING 
Sidestream smoke is richer in certain combustion products than mainstream smoke. 
Sidestream smoke m~ contain for example 5 times more carbon monoxide, 3 times 
more tar and nicotine, 4 times more benzo-(a) pyrene and 50 times more ammonia 
than mainstream smoke, and also much higher amounts of nitro1samines. In spite 
of relatively high concentrations of certain toxic agents in sidestream smoke, 
the levels measured even in ill-ventilated spaces (workplace, offices, bars and 
restaurants) most probably have no adverse physical effects in healt~adults. 
Passive smoking is more "unpleasant" (irritation of eyes, nose and throat due 
to aldehydes, ammonia and nitrogen oxides) than "unhealthy" to healthy adults. 
5. EPIDEMIOLOGICAL DATA ON THE H&ALTH EFFECTS OF CIGARETTE SMOKING 
People who smoke cigarettes report more illness and disability than people who 
never smoked cigarettes. 
As regards the overall mortality ratio, for current male US cigarette smokers 
it is about 1.7 compared to nonsmokers (i.e. 70 ~excess mortality). Although 
the lung cancer mortality ratio for cigarette smokers - as compared to non-
smokers - is much higher than the mortality ratio for cardiovascular disease, 
numerically, the excess mortality from cardio-vascular disease is much higher 
because diseases of heart and blood vessels also occur ver,y frequently among 
non-smokers. This implies that the major cause of death from cigarette smoking 
is cardiovascular disease. 
Cigarette smoking has been demonstrated to be ca~sally related or significantly 
associated with several diseases. These include cardiovascular disease, cancer 
(in particular of the lung), chronic bronchitis and emphysema, and peptic ulcer. 
In addition it has effects on metabolism,on the immune s,ystem,on the foetus, and 
probably represent's a genetic risk. Smoking m~ also interact with exposure to 
other agents at work to induce or increase adverse health effects. 
There is some evidence that young infants, patients with chronic heart or lung 
disease are at particular risk of suffering from health effects from passive 
smoking. 
5.1 Cardiovascular diseases 
Cigarette smoking in man is associated with fibrotic ad hyaline changes in small 
arteries and arterioles in the myocardium. 
In many developed countries coronar,y heart disease is the main cause of death. 
Cigarette smoking has been proven to be a causative risk factor - though not the 
only risk factor - for non-fatal myocardial infarction, sudden cardiac death, 
coronar,y heart disease and arteriosclerotic peDPheral vascular disease. 
Epidemiological data on the association between smoking and angina pectoris 
and cerebrovascular disease are inconclusive. 
No epidemiological data are availablem a possible association between the 
consumption of cigarettes with a high carbon monoxide yield and the occurrence 
of ischaemic heart disease, but this compound is known to pl~ a major role in 
the development of cardiac and vascular diseases. 
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5.2 Cancer 
As regards lung cancer: 
- Cigarette smoking is the major cause of lung cancer in both men and women who 
have a 10-fold higher risk of death from lung cancer than non-smokers. 
A dose-response relationship exists between the risk of developing lung cancer 
and the number of cigarettes smoked per d~ (a 20-fold risk among persons 
smoking two packs or more per d~). 
The risk of lung cancer is inversely proportional to the age at which smoking 
was started, it increases with increasing degree of inhalation and among ex-
smokers declines as the interval of abstinence increases. In women it is 
increasing more rapidly than any other cause of death. 
As regards other cancers: 
Many epidemiological studies have demonstrated that cigarette smoking is a 
significant causative factor in the development of cancer of the larynx, 
oral cavity (lips, "tongue, palate, gums, buccal mucosa, oropharynx) and 
oesophagus. A synergism between the use of alcohol and cigarette smoking in 
the induction of lar,yngeal, oral and oesophageal cancer has been demonstrated. 
- Numerous retrospective studies have shown a significant association between 
cigarette smoking and bladder cancer in men and women, the risk is about twice as 
high as for non-smokers. An association has also been found for cancer of 
the kidneys in men. 
According to both pro- and retrospective epidemiological studies, there is a 
significant association between cigarette smoking and cancer of the pancreas. 
The risk of developing pancreas cancer is approximately five times higher 
for a heavy smoker (two packs a d~) than for a non-smoker. 
5•3 Chronic bronchitis and em£Qysema 
Numerous retrospective and prospective studies have shown higher mortality rates 
from chronic bronchitis and emphysema among cigarette smokers than among non-
smokers. There is a good deal of evidence that not only adult but also young 
cigarette smokers have respirator,y complaints (regular cough, phlegm production, 
wheezing) more frequently than non-smokers. Pulmonar,y qysfunction and chronic 
obstructive lung disease are associated with cigarette smoking. 
5·4 Effects on the immune system 
That cigarette smoking can affect the immune system has been shown both in man 
ad experimental animals. In smokers the number of alveolar macrophages is higher 
than in non-smokers; physiological and ultrastructural changes have been observed 
in macrophages collected in smokers. 
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Humoral immunity has been found to be reduced in smokers. Alterations in the 
cell-mediated immunity, leucocytosis and hypereosinophilia have also been 
reported to occur in smokers. An increased incidence of clinical influenza 
has been noticed among smokers and more cases of urinar,y tract infections in 
smoking than in non-smoking women. 
Tobacco and tobacco smoke extracts possess antigenic activity: several tobacco 
antigens have been isolated. A variety of clinical conditions have been 
attributed to allergic reactions to tobacco or its smoke (asthma, rhinitis, 
dermatitis, migraine). 
5•5 Genetic risks 
In a recent review on the genetic risks of cigarette smoking an expert group of 
the International Commission for Protection against Environmental Mutagens and 
Carcinogens ( ICPEMC) concluded that: 
1. Cigarette smoke contains many mutagens. Smokers who inhale must be 
expected to absorb significant quantities of mutagens, and at least 
some of them m~ be expected to reach the gonads. 
2. There is experimental evidence which suggests the occurrence of 
genetic damage to lymphoqytes and spermatozoa of smokers. 
3. There is one study on heritable effects in humans which indicates a 
significant correlation between paternal smoking and the rate of 
perinatal mortality and also the frequency of congenital abnormalities. 
It has been clearly demonstrated that compounds of tobacco smoke cross 
the placenta and affect the foetus and subsenquently the neonate. 
Babies from women who smoked during pregnancy are on the average 200 g 
lighter~an babies born to comparable women who did not smoke. 
Retardation of foetal growth is a consequence of a direct effect of 
cigarette smoke compounds on the foetus such as nicotine, cyanide, 
carbon monoxide. 
Smoking during pregnanqy is a definite risk factor for spontaneous 
abortion and for foetal and neonatal death. 
5.6 Effects on metabolism 
A series of recent studies have clearly demonstrated that women who smoke and 
use oral contraceptives have a considerably greater risk of myocardial infarctior. 
than non-smokers who take the pill. This relative risk increases with the number 
of cigarettes smoked per d~. There is also some evidence that cigarette smokin@ 
alters the metabolism of both micro-nutrients (e.g. vitamin C, B6 and B12 ) and 
macro-nutrients such as lipids, proteins and carbohydrates. 
- 1- .Annex C 
5·7 Cigarette smoking at work 
Smoking at work m~ interact with exposure to other agents at work to induce or 
increase adverse health effects: 
Tobacco products m~ serve as vectors by becoming contaminated with toxic 
compounds found in the workplace (e.g. formaldehyde{ organotin, methyl 
parathion, lead and inorganic fluorides and mercury). 
- Workplace chemicals m~ be transformed into more harmful agents by smoking: 
polymer fume fever. This disease is attributed to the decomposition of 
polytetrafluorethylene by lit cgarettes, and inhalation of the decomposition 
products together with the smoke. 
Toxic constituents of tobacco smoke m~ also occur in the workplace and thus 
m~ increase exposure to the agent (carbon monoxide, hydrogen cyanide and 
methylene chloride). 
- Additive effect of smoking and occupational exposure. Coal dust (chronic 
obstructuve lung disease), cotton dust (reduced pulmonar,y function) and 
chlorine (reduced diffusing capacity of the lung). 
S,ynergistic effect of smoking ad toxic materials found at the workplace. A 
dramatic example is the situation with occupational exposure to asbestos. 
Asbestos workers who smoke have several times the lung cancer risk of other 
smokers and up to 90 times the risk of non-smokers not exposed to asbestos. In 
addition, recent studies have shown that asbestos workers who smoke have a 
higher risk of developing asbestosis than those workers who do not smoke. 
In uranium miners cancer of the respirator,y tract among smoking miners occurred 
9 times more frequently than among non-miners with similar smoking habits. 
In rubber workers the combination of smoking and occupational exposure 
significantly increased the probability of developing early pulmonar,y disability. 
A significantly higher incidence of chronic bronchitis was observed among smoking 
gold miners (5o%) than among non-smoking miners (8 ~). 
6. CONCLUSIONS 
- See paragraph 37 of the report. 
Annex D 
(referred to in paragraph 50) 
CO:MP ARISON OF EXCISE DUTY RATES ON CIGARETTES IN THE MEMBER STATES 
Table 6 
Incidence of exoise duty (including VAT) on cigarettes 
Excise duty (including VAT) on cigarettes in Member States 
proportion of the average for the Community 
1973 - 1980 
Average(d~ty 
in EUA 1 B DK D .F IRL I 
20 cigarettes at 1. 7. 7 3 0.376 = 100 69 235 168 59 71 52 
20 cigarettes at 1.7.80 o. 728 = 100 84 262 109 50 91 50 
(l)EUA rates in force on 1.7.1980 
Table 7 
as a 
L NL UK 
58 91 97 
50 86 117 
Comparison of excise duty (including VAT) on cigarettes with consumer price indices 
Indices of the evolution of excise duty (including VAT) on 
cigarettes in Member States compared with the respective 
price indices, 1973 to 1980 
B DK D F IRL I L NL UK 
.. 20 cigarettes at 1.7.73 100 100 100 100 100 100 100 100 100 
A 20 cigarettes at 1.7.80 236 216 126 165 248 186 168 182 234 
. ' Consumer price index 
' at 1.7. 73 100 100 100 100 100 100 100 100 100 
Consumer price index 
B at 1. 7.80 173 209 138 210 268 -296 . -163 . 164 286 
B-i.x 
-
100 Change in 1980 duty rate 
A required to match change 
in price index 
197 3/80. ( -%) -27 -3 +10 +27 +8 '*59 -3 -10 +23 
Source (Tables 6 and 7}: Based on tables from the Report from the Commission to the 
Council on scope for con~gence of tax s,ystems in the 
Community (COM (80) 139)• Bulletin of the European 
Communities, Supplement 1/80, Tables 5 and 6. 

